Parnassus Investments’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Parnassus Investments’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-12,000	Closed	-$342K	–	101
2015 Q2	$342K	Buy	12,000 +3,000	+33%	+$87.4K	﹤0.01%	91
2015 Q1	$246K	Buy	9,000 +3,700	+70%	+$102K	﹤0.01%	98
2014 Q4	$140K	Buy	5,300 +2,300	+77%	+$67.3K	﹤0.01%	108
2014 Q3	$90K	Buy	+3,000	New	+$92.9K	﹤0.01%	109

Other funds holding MR

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

GAM

Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Holowesko Partners Nassau, Bahamas $395M AUM 15.17% 1-Year Est. Return

Parnassus Investments's MR Position: Q3 2015 in Review

Parnassus Investments sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q3 2015, closing a stake of 12,000 shares — an estimated $342K sold.

Parnassus Investments first reported a position in MR in Q3 2014 and held it in 4 quarters. The position peaked at $342K in Q2 2015. 105 funds tracked by Wall St. Rank hold MR as of Q3 2015.

Parnassus Investments reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q3 2015 after selling out during the quarter.
Parnassus Investments sold 12,000 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q3 2015, an estimated $342K.
Parnassus Investments first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q3 2014 and held it in 4 quarters.
Parnassus Investments's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $342K in Q2 2015.
105 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q3 2015.

Based on Parnassus Investments's 13F filing for Q3 2015, filed 6 Nov 2015.